183 related articles for article (PubMed ID: 37998338)
41. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
[TBL] [Abstract][Full Text] [Related]
42. Long noncoding RNA LSINCT5 is upregulated and promotes the progression of esophageal squamous cell carcinoma.
Jing L; Lin J; Zhao Y; Liu GJ; Liu YB; Feng L; Yang HY; Cui WX; Zhang XH
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5195-5205. PubMed ID: 31298370
[TBL] [Abstract][Full Text] [Related]
43. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.
Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L
Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100
[TBL] [Abstract][Full Text] [Related]
44. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
[TBL] [Abstract][Full Text] [Related]
45. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
[TBL] [Abstract][Full Text] [Related]
46. Identification of a Metastasis-Related Protein IFI16 in Esophageal Cancer using a Proteomic Approach.
Wang Z; Sheng B; Wei Z; Li Y; Liu Z
J Cancer; 2022; 13(5):1630-1639. PubMed ID: 35371314
[No Abstract] [Full Text] [Related]
47. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
48. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
[TBL] [Abstract][Full Text] [Related]
49. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
Zhao X; Tang YP; Wang CY; Wu JX; Ye F
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
[TBL] [Abstract][Full Text] [Related]
50. Overexpressed COL3A1 has prognostic value in human esophageal squamous cell carcinoma and promotes the aggressiveness of esophageal squamous cell carcinoma by activating the NF-κB pathway.
Zhou J; Yang Y; Zhang H; Luan S; Xiao X; Li X; Fang P; Shang Q; Chen L; Zeng X; Yuan Y
Biochem Biophys Res Commun; 2022 Jul; 613():193-200. PubMed ID: 35598375
[TBL] [Abstract][Full Text] [Related]
51. Distribution and prognostic impact of M1 macrophage on esophageal squamous cell carcinoma.
Jiang CH; Liang WH; Li FP; Xie YF; Yuan X; Zhang HJ; Li M; Li JF; Zhang AZ; Yang L; Liu CX; Pang LJ; Li F; Hu JM
Carcinogenesis; 2021 Apr; 42(4):537-545. PubMed ID: 33269791
[TBL] [Abstract][Full Text] [Related]
52. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.
Zhang W; Zhou Y; Li C; Xu S; Li M; Liu W; Ma Y; Wang H
Anal Cell Pathol (Amst); 2020; 2020():2872479. PubMed ID: 33381388
[TBL] [Abstract][Full Text] [Related]
53. IL-11 activated by lnc-ATB promotes cell proliferation and invasion in esophageal squamous cell cancer.
Yang SM; Li SY; Hao-Bin Y; Lin-Yan X; Sheng X
Biomed Pharmacother; 2019 Jun; 114():108835. PubMed ID: 30954889
[TBL] [Abstract][Full Text] [Related]
54. HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma.
Yuan X; Liu K; Li Y; Zhang AZ; Wang XL; Jiang CH; Liang WH; Zhang HJ; Pang LJ; Li M; Yang L; Qi Y; Zheng Q; Li F; Hu JM
Clin Transl Oncol; 2021 Nov; 23(11):2382-2393. PubMed ID: 34075547
[TBL] [Abstract][Full Text] [Related]
55. Plantamajoside inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells.
Li X; Chen D; Li M; Gao X; Shi G; Zhao H
Biomed Pharmacother; 2018 Jun; 102():1045-1051. PubMed ID: 29710521
[TBL] [Abstract][Full Text] [Related]
56. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
57. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
[TBL] [Abstract][Full Text] [Related]
58. IFI16/Ifi202 released from breast cancer induces secretion of inflammatory cytokines from macrophages and promotes tumor growth.
Lim GY; Cho SW; Ka NL; Lee KH; Im SA; Kim SS; Hwang S; Lee MO
J Cell Physiol; 2023 Jul; 238(7):1507-1519. PubMed ID: 37062941
[TBL] [Abstract][Full Text] [Related]
59. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
60. IQGAP1 enhances cell invasion and matrix metalloproteinase-2 expression through upregulating NF-κB activity in esophageal squamous cell carcinoma cells.
Zhang Z; Wei Y; Li X; Zhao R; Wang X; Yang Z; Li T; Wang X; Li X; Wang X
Gene; 2022 May; 824():146406. PubMed ID: 35276237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
